UNICYCIVE THERAPEUTICS, INC. Leasehold Improvements, Gross
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Leasehold Improvements, Gross of $21.00 thousand as of 2024-03-31, per its 10-Q filed 2024-05-13.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, before Accumulated Depreciation, Depletion, and Amortization
us-gaap:LeaseholdImprovementsGross · last filed 2024-05-13
- 2024-03-31: Leasehold Improvements, Gross $21.00K.
- 2023-12-31: Leasehold Improvements, Gross $21.00K.
- 2023-09-30: Leasehold Improvements, Gross $21.00K.
- 2023-06-30: Leasehold Improvements, Gross $21.00K.
| Period end | Leasehold Improvements, Gross |
|---|---|
| 2024-03-31 | $21.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $21.00K 10-Q · filed 2024-05-13 |
| 2023-09-30 | $21.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $21.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $15.00K 10-Q · filed 2023-05-16 |
| 2022-12-31 | $15.00K 10-K · filed 2024-03-28 |
| 2022-09-30 | $15.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $15.00K 10-Q · filed 2022-08-15 |
| 2022-03-31 | $15.00K 10-Q · filed 2022-05-12 |
| 2021-12-31 | $15.00K 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |